Bio-Rad Reports 2 Percent Lift in Q2 Sales | GenomeWeb

NEW YORK (GenomeWeb) — Bio-Rad reported after the close of the market on Tuesday a 2 percent increase in second quarter revenues despite essentially flat sales for its Life Science segment.

For the quarter ended June 30, the Hercules, Calif.-based firm reported revenues of $536.8 million compared to $525.3 million in Q2 2013 and falling short of the consensus analyst estimate of $537.6 million.

On a currency-neutral basis, quarterly revenues increased 1 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.